Delayed therapeutic hypothermia protects against the myocardial no-reflow phenomenon independently of myocardial infarct size in a rat ischemia/reperfusion model

International Journal of Cardiology

Volumn 236, Issue , 2017, Pages 400-404

  Dai, Wangde ^a,b   Hale, Sharon ^a   Kloner, Robert A ^a,b  

^a HUNTINGTON MEDICAL RESEARCH INSTITUTES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Microvascular obstruction; Myocardial infarction; Myocardial ischemia reperfusion; No reflow; Therapeutic hypothermia

Indexed keywords

SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OCCLUSION; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; HEART PROTECTION; INDUCED HYPOTHERMIA; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; NO REFLOW PHENOMENON; NONHUMAN; PILOT STUDY; RAT; THERAPY EFFECT; ANIMAL; DISEASE MODEL; HEART INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT; TIME FACTOR;

ANIMALS; DISEASE MODELS, ANIMAL; HYPOTHERMIA, INDUCED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; NO-REFLOW PHENOMENON; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 85009761352     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2017.01.079     Document Type: Article

References (19)

1. [1] Kloner, R.A., Ganote, C., Jennings, R.B., The “no-reflow” phenomenon following temporary coronary occlusion in the dog. J. Clin. Invest. 54 (1974), 1496–1508.
2. [2] Reffelmnan, T., Kloner, R.A., Microvascular reperfusion injury: rapid expansion of anatomic no-reflow during reperfusion in the rabbit. Am. J. Physiol. Heart Circ. Physiol. 283 (2002), H1099–H1107.
3. [3] Reffelmann, T., Hale, S.L., Dow, J.S., Kloner, R.A., No-reflow phenomenon persists long-term after ischemia/reperfusion in the rat and predicts infarct expansion. Circulation 108 (2003), 2911–2917.
4. [4] Kloner, R.A., Alker, K.J., The effect of streptokinase on intramyocardial hemorrhage, infarct size, and the no-reflow phenomenon during coronary reperfusion. Circulation 70 (1984), 513–521.
5. [5] Herring, M.J., Dai, W., Hale, S.L., Kloner, R.A., Rapid induction of hypothermia by the ThermoSuit system profoundly reduces infarct size and anatomic zone of no-reflow following ischemia-reperfusion in rabbit and rat heart. J. Cardiovasc. Pharmacol. Ther. 20 (2015), 193–202.
6. [6] Kloner, R.A., No-reflow phenomenon. Maintaining vascular integrity. J. Cardiovasc. Pharmacol. Ther. 16 (2011), 244–250.
7. [7] Wu, K.C., Zerhouni, E.A., Judd, R.M., et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 87 (1998), 765–772.
8. [8] Bolognese, L., Carrabba, N., Parodi, G., et al. Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction. Circulation 109 (2004), 1121–1126.
9. [9] Hale, S.L., Kloner, R.A., Myocardial temperature in acute myocardial infarction: protection with mild regional hypothermia. Am. J. Phys. 273:1 Pt 2 (1997), H220–H227.
10. [10] Hale, S.L., Dae, M.W., Kloner, R.A., Hypothermia during reperfusion limits “no-reflow” injury in a rabbit model of acute myocardial infarction. Cardiovasc. Res. 59 (2003), 715–722.
11. [11] Hale, S.L., Herring, M.J., Kloner, R.A., Delayed treatment with hypothermia protects against the no-reflow phenomenon despite failure to reduce infarct size. J. Am. Heart Assoc., 2, 2013, e004234, 10.1161/JAHA.112.004234.
12. [12] Menees, D.S., Peterson, E.D., Wang, Y., et al. Door-to –balloon time and mortality among patients undergoing primary PCI. N. Engl. J. Med. 369 (2013), 901–909.
13. [13] Kloner, R.A., Dai, W., Hale, S., Shi, J., Approaches to improving cardiac structure and function during and after an acute myocardial infarction: acute and chronic phases. J. Cardiovasc. Pharmacol. Ther. 21 (2016), 363–367.
14. [14] Hausenloy, D.J., Botker, H.E., Engstrom, T., et al. Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations. Eur. Heart J., 2016 Apr 26 (pii: ehw145).
15. [15] Gerczuk, P.Z., Kloner, R.A., An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials. J. Am. Coll. Cardiol. 59 (2012), 969–978.
16. [16] Heusch, G., Rassaf, T., Time to give up on cardioprotection? A critical appraisal of clinical studies on ischemic pre-, post-, and remote conditioning. Circ. Res. 119:5 (2016), 676–695.
17. [17] Heusch, G., The coronary circulation as a target of cardioprotection. Circ. Res. 118:10 (2016), 1643–1658.
18. [18] Götberg, M., Olivecrona, G.K., Koul, S., et al. A pilot study of rapid cooling by cold saline and endovascular cooling before reperfusion in patients with ST-elevation myocardial infarction. Circ. Cardiovasc. Interv. 3:5 (2010), 400–407.
19. [19] Erlinge, D., Götberg, M., Lang, I., et al. Rapid endovascular catheter core cooling combined with cold saline as an adjunct to percutaneous coronary intervention for the treatment of acute myocardial infarction. The CHILL-MI trial: a randomized controlled study of the use of central venous catheter core cooling combined with cold saline as an adjunct to percutaneous coronary intervention for the treatment of acute myocardial infarction. J. Am. Coll. Cardiol. 63:18 (2014), 1857–1865.